January 24, 2020

Epizyme’s Tazverik receives accelerated approval from US FDA

Epizyme has announced the US Food and Drug Administration (FDA) has granted its epithelioid sarcoma (ES) therapy Tazverik (tazemetostat) accelera ...

Read More
January 24, 2020

AstraZeneca commits to near-zero GWP asthma inhalers

UK pharmaceutical firm AstraZeneca has committed to launching its next-generation asthma and chronic pulmonary disease inhaler with near-zero car ...

Read More
January 22, 2020

EMA suspends picato as a precaution

EMA is recommending that patients stop using Picato (ingenol mebutate), a gel for treating the skin condition actinic keratosis, while ...

Read More
January 22, 2020

Lilly company strengthens parenteral manufacturing operations

Eli Lilly and Company has unveiled plans to invest over $470 million and create more than 460 new jobs in Durham, NC. The project will bring ...

Read More
January 20, 2020

US judge cuts damages in Johnson & Johnsons Risperdal...

Judge Kenneth Powell of the Philadelphia Court of Common Pleas, US has reduced the $8bn punitive damages verdict in Johnson & Johnson (J& ...

Read More
January 20, 2020

Skyepharma set-up for serialization and aggregation.

Since 2018, oral dosage CDMO Skyepharma radically updated and expanded its packaging capabilities, opening new packaging lines equipped for seria ...

Read More
January 18, 2020

A medical and pharmaceutical cluster is developing in the...

At present, a medical and pharmaceutical cluster is developing in the Moscow Region. In this regard, there are plans to build several major medic ...

Read More
January 18, 2020

Drugmakers slash prices

Global pharmaceutical majors and generic drugmakers chopped by 53% on average prices of some of their off-patent products in the latest bidding r ...

Read More
January 16, 2020

Sun Pharma will be the exclusive development for Rockwell...

Sun Pharmaceutical Industries’ subsidiary has entered into exclusive licensing and supply agreements with Rockwell Medical Inc.&n ...

Read More